Cargando…
The relationship of p53 immunostaining to survival in carcinoma of the lung.
In this study 125 primary lung tumours have been immunostained with a panel of 5 anti-p53 antibodies (PAb240, PAb421, PAb1801, CM-1 and C19). These antibodies recognise different epitopes over the full extent of the p53 gene. It is generally believed that immunolabelling identifies only mutant p53 p...
Autores principales: | McLaren, R., Kuzu, I., Dunnill, M., Harris, A., Lane, D., Gatter, K. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977415/ https://www.ncbi.nlm.nih.gov/pubmed/1329907 |
Ejemplares similares
-
The Potential Value of EGFR and P53 Immunostaining in Tumors of the Urinary Bladder
por: Ibrahim, N, et al.
Publicado: (2009) -
p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
por: Sung, You-Na, et al.
Publicado: (2022) -
CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia
por: Neal, Daniel J., et al.
Publicado: (2020) -
Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer
por: Kamoshida, S, et al.
Publicado: (2007) -
The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer
por: Egger, Eva K., et al.
Publicado: (2023)